Metabolic-immune crosstalk in head and neck squamous cell carcinoma: CD44 and APP identified as causal therapeutic targets via integrated lactylation-Mendelian randomization analysis. - Zhang X; Deng Q; Yang L; Yan M (Frontiers in immunology, 2026)